The adjuvant LT-K 63 has been reported to enhance long-term persistence of vaccine-specific AbSCs in BM of neonatal mice when administered with the pneumococcal conjugate vaccine Pnc 1-TT.
Ef ónæmisglæðirinn LT-K 63 er gefinn með próteintengdu fjölsykrubóluefni gegn pneumókokkum (Pnc 1-TT) eykur hann lifun AbSCs, sértækra fyrir bóluefnið.